Ultrashort‑Chain PFAS: Why They Matter and How to Measure Them

While the regulatory focus in the U.S. has largely been on well-studied PFAS, such as PFOA and PFOS, many stakeholders are now turning their attention to a new category of compounds: Ultrashort-Chain PFAS. In this post, we cover what ultrashort-chain PFAS are, where they come from, and why they present a unique challenge to water professionals. We will also cover an ultrashort-chain PFAS method developed by Pace^® that uses direct aqueous injection to quantify C1–C4 PFAS at low reporting limits.

Where Do Ultrashort-Chain PFAS Come From?

Ultrashort-chain PFAS in water systems often originate as degradation byproducts of other fluorinated chemicals in use across industry and commerce. They are generated when precursor PFAS and related fluorinated compounds from industrial discharge, wastewater effluent, urban runoff, and oxidative treatment processes (such as ozonation, advanced oxidation, and some chlorination practices) degrade longer-chain compounds into more mobile short and ultrashort-chain species.

Another potentially significant point of origin is the atmospheric degradation of volatile fluorinated substances, such as certain refrigerants, which oxidize in the atmosphere and then return to watersheds via precipitation as highly mobile ultrashort-chain PFAS. For drinking water and wastewater professionals, this creates a diffuse, basin‑scale source that is only partially controllable at the point of discharge.

Lastly, as regulators and manufacturers have moved away from legacy C8 PFAS, like PFOA and PFOS, some product sectors have shifted toward short‑ and ultrashort‑chain PFAS as replacements. These compounds deliver similar attributes, such as water and oil repellency or surfactant behavior, while being marketed as safer.

The Problem with Ultrashort-Chain PFAS

Ultrashort-chain PFAS are often described as “less bioaccumulative,” and in some cases, less systemically toxic than classic long-chain PFAS like PFOA and PFOS because some have been shown to clear from the body more quickly. However, that does not mean they are non-toxic, and some ultrashort-chain compounds (like TFA and PFPrA) have shown equal or even higher acute toxicity to certain aquatic organisms than longer-chain PFAS. Other studies have found that these compounds now dominate total PFAS exposure and link some short‑chain PFAS to altered hormones and thyroid function in fetuses and newborns.

For many common PFAS (like the perfluoroalkyl acids), shorter-chain compounds are more water‑soluble and sorb less to soils and carbon, so they move more readily with groundwater and surface water than their longer‑chain counterparts. They can also be more challenging to remove using conventional treatment. Our own PFAS treatability studies have found that shorter-chain PFAS break through filtration membranes more quickly, necessitating more frequent media changes.

Regulatory Outlook for Ultrashort-Chain PFAS

Several states have drinking water regulations focusing on longer short-chain (C4+) and legacy compounds, but as of this moment, no state standards directly target ultrashort-chain PFAS as individual regulated contaminants. At the federal level, there are EPA Regional Screening Levels (RSL) for TFSI and PFPrA in non-drinking water matrices, e.g., soil and groundwater. For drinking water specifically, EPA’s discussions for the next Unregulated Contaminant Monitoring Rule (UCMR 6) include adding ultrashort-chain PFAS like TFA (C2) and PFPrA (C3), but they are among the many contaminants being considered. While UCMR does not establish enforceable limits, the data would go a long way toward understanding human exposure to specific ultrashort-chain PFAS through drinking water.

A few states and regional utilities are moving ahead on their own. For instance, California’s statewide PFAS investigation and quality-assurance plan calls for methods that can detect C1–C3 PFAS in drinking water. Utilities in North Carolina’s Cape Fear basin also routinely track PFPrA and other ultrashort-chain PFAS under consent orders and special studies, even though formal state standards do not yet address them.

Analytical limitations have been a major challenge in monitoring and regulating ultrashort-chain PFAS. Because these molecules are extremely polar, they are poorly retained and separated by standard reversed-phase LC methods, leading to low recoveries and inconsistent quantification. In addition, matrix effects can severely suppress signals, and many labs lack the validated protocols and suitable internal standards necessary to overcome this issue.

Ultrashort-Chain PFAS Testing by Direct Inject

Ultrashort‑chain PFAS are not covered in currently published PFAS methods such as EPA 537.1, 533, or 1633, so a separate analytical approach is needed to quantitate these compounds in potable and non-potable water. To address this gap, Pace^® developed the Ultrashort‑Chain PFAS by Direct Inject method, a LC‑MS/MS method based in part on an EPA method currently under development. The Pace^® method quantifies seven target ultrashort-chain compounds plus two C4 short‑chain PFAS that work very well by this approach. (Exhibit 1)

Instead of using a traditional solid‑phase extraction step, our method relies on direct aqueous injection, i.e., a measured aliquot of the sample is injected directly onto the LC‑MS/MS system. This approach reduces sample handling, minimizes potential losses of very polar compounds, and supports low‑ng/L reporting limits when combined with isotope‑dilution quantitation.

Sample collection requirements are straightforward: One 15‑mL tube filled with approximately 10 mL of sample provides sufficient volume for initial analysis and any required reruns while maintaining a 28‑day holding time, consistent with EPA 1633 and ASTM D8421. At present, the method is validated for aqueous matrices only.